{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:55:47Z","timestamp":1791172547233,"version":"4.1.0"},"reference-count":90,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T00:00:00Z","timestamp":1299628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The clinical, morphological, and genetic heterogeneity of chronic myelomonocytic leukaemia (CMML), has made it difficult to clearly assign this entity to a distinct haematological category. In 2001, the World Health Organization transferred CMML to a new category of mixed myeloproliferative\/myelodysplastic disorders, which was maintained in the last revision in 2008. Considering the rare occurrence of CMML, most pharmacotherapeutic and transplant studies combined CMML with myelodysplastic syndrome cases, but some clinical trials specifically investigated the use of demethylating agents in CMML and demonstrated stabilization of the haematological situation or even complete remission in subsets of patients. Information on the significance of other drugs is very limited. Allogeneic haematopoietic stem cell transplantation (HSCT) remains the only curative option for patients with CMML. Molecular studies revealed various novel genetic alterations in CMML \u2013 notably of the <jats:italic>JAK2<\/jats:italic>, <jats:italic>TET2<\/jats:italic>, <jats:italic>CBL<\/jats:italic>, <jats:italic>IDH<\/jats:italic>, or <jats:italic>RUNX1<\/jats:italic> and <jats:italic>RAS<\/jats:italic> genes. This review summarizes the current status of pharmacotherapy and transplantation in CMML and outlines recent results of molecular research for diagnosis of this heterogeneous entity.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2011.08631.x","type":"journal-article","created":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T02:43:54Z","timestamp":1299725034000},"page":"149-167","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia"],"prefix":"10.1111","volume":"153","author":[{"given":"Ulrike","family":"Bacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Schnittger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,9]]},"reference":[{"key":"e_1_2_14_2_1","first-page":"110","volume-title":"WHO Classification of Haematopoietic and Lymphoid Tissues","author":"Arber D.A.","year":"2008"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22457"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0977-1"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10869"},{"key":"e_1_2_14_6_1","first-page":"68","volume-title":"WHO Classification of Haematopoietic and Lymphoid Tissues","author":"Bain B.J.","year":"2008"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb02771.x"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb06734.x"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.9.2819"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.745"},{"key":"e_1_2_14_11_1","first-page":"866","article-title":"Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukaemia: a retrospective analysis of 83 patients from a single institution","volume":"89","author":"Breccia M.","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403172"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-061176"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.141"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06081.x"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403688"},{"key":"e_1_2_14_17_1","first-page":"3671","article-title":"Report of an international working group to standardize response criteria for myelodysplastic syndromes","volume":"96","author":"Cheson B.D.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_14_18_1","article-title":"Activity of azacitidine in chronic myelomonocytic leukaemia. 2010 ASCO annual meeting","volume":"28","author":"Costa R.B.","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810069"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704381"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-224352"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2754"},{"issue":"1","key":"e_1_2_14_23_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3310\/hta14Suppl1-10","article-title":"Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia","volume":"14","author":"Edlin R.","year":"2010","journal-title":"Health Technology Assessment"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2005.07.012"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705369"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.156"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70003-8"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-230698"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-299"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07697.x"},{"key":"e_1_2_14_31_1","first-page":"16","article-title":"A randomized phase II study of low\u2010dose cytosine arabinoside (LD\u2010AraC) plus granulocyte\u2010macrophage colony\u2010stimulating factor (rhGM\u2010CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukaemia. EORTC leukaemia co\u2010operative group","volume":"8","author":"Gerhartz H.H.","year":"1994","journal-title":"Leukaemia"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(97)00192-6"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0330"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819042000207271"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-679X(04)75028-1"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-194548"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0910063"},{"key":"e_1_2_14_38_1","first-page":"408","article-title":"Sensitivity to imatinib but low frequency of the TEL\/PDGFRbeta fusion protein in chronic myelomonocytic leukaemia","volume":"88","author":"Gunby R.H.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-082404"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205690"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2002.v8.pm11939606"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21792"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.05.008"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09586"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.1361"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.011205"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-215814"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.52"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.375"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03552.x"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4333"},{"key":"e_1_2_14_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.48"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.391"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.11.012"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1898"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2004.10.001"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0165"},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.7503"},{"key":"e_1_2_14_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712391105"},{"key":"e_1_2_14_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1992.tb01587.x"},{"key":"e_1_2_14_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704472"},{"key":"e_1_2_14_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07117.x"},{"key":"e_1_2_14_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.366"},{"key":"e_1_2_14_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-103960"},{"key":"e_1_2_14_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.840"},{"key":"e_1_2_14_66_1","first-page":"76","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Orazi A.","year":"2008"},{"key":"e_1_2_14_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2009.065904"},{"key":"e_1_2_14_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-009-0726-x"},{"key":"e_1_2_14_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22186"},{"key":"e_1_2_14_70_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1325"},{"key":"e_1_2_14_71_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2112"},{"key":"e_1_2_14_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08240"},{"key":"e_1_2_14_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-066076"},{"key":"e_1_2_14_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4165"},{"key":"e_1_2_14_75_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11262"},{"key":"e_1_2_14_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-274704"},{"key":"e_1_2_14_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830460103"},{"key":"e_1_2_14_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2677"},{"key":"e_1_2_14_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2008.03.001"},{"key":"e_1_2_14_80_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.030957"},{"key":"e_1_2_14_81_1","article-title":"Allogeneic stem cell transplantation in patients with chronic myelomonocytic leukaemia: the impact of WHO classification and of the conditioning regimen on the transplantation outcome. Annual meeting of the EBMT 2010","volume":"45","author":"Symeonidis A.","year":"2010","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_14_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.69"},{"key":"e_1_2_14_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.59"},{"key":"e_1_2_14_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050569"},{"key":"e_1_2_14_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(00)00159-4"},{"key":"e_1_2_14_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.01.020"},{"key":"e_1_2_14_87_1","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/blood.V88.7.2480.bloodjournal8872480","article-title":"A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukaemia. Groupe Francais des Myelodysplasies and European CMML Group","volume":"88","author":"Wattel E.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_14_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.08.004"},{"key":"e_1_2_14_89_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M404298200"},{"key":"e_1_2_14_90_1","doi-asserted-by":"publisher","DOI":"10.1309\/HRJ1XKTD77J1UTFM"},{"key":"e_1_2_14_91_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02133.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2011.08631.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2011.08631.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:44:08Z","timestamp":1697413448000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2011.08631.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,9]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1365-2141.2011.08631.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08631.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,9]]},"assertion":[{"value":"2011-03-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}